Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Methyltransferase like 15 pseudogene 3 (METTL15P3) is classified as a **pseudogene**, which means it is a non-functional DNA segment derived from a functional gene and does not produce a functional protein product[1][4]. While METTL15 (the parent gene) encodes for an RNA methyltransferase, the METTL15P3 locus itself is not known to encode any functional protein or play a direct role in biological pathways or disease processes[1][4]. Pseudogenes such as METTL15P3 are generally regarded as "junk DNA," though occasionally they may be transcribed into non-functional RNA or, in rare cases, affect gene regulation[4]. There are no known drugs, disease links, or targetable biology for METTL15P3, and it is not regarded as a therapeutic target[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methyltransferase like 15 pseudogene 3 (METTL15P3).